Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Euvichol? | Company | EuBiologics Co., Ltd |
|---|---|---|---|
| Classification | Vaccine | Active Ingredient | ① V. cholerae O1 Inaba Cairo 48 classical biotype, Heat inactivated 300 L.E.U* ② V. cholerae O1 Inaba Phil 6973 El Tor biotype, Formalin inactivated 600 L.E.U ③ V. cholerae O1 Ogawa Cairo 50 classical biotype, Formalin inactivated 300 L.E.U ④ V. choler |
| Reference Product | Approval Date | 2015 | |
| Indication | Prevention of Cholera caused by Vibrio cholerae but the efficacy against Vibrio cholerae serogroup O139 was not demonstrated. |
||
| Description |
Euvichol? is a liquid formulation of Oral Cholera Vaccine containing O1 and O139 of Vibrio cholerae inactivated by heat or formalin. Euvichol? was developed by EuBiologics Co., Ltd in cooperation with International Vaccine Institute (IVI) and fulfills WHO requirements for Oral Cholera Vaccine.
|
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.